Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer.

Kawamura, Junichiro; Sugiura, Fumiaki; Sukegawa, Yasushi; Yoshioka, Yasumasa; Hida, Jin-Ichi; Hazama, Shoichi; Okuno, Kiyotaka

Kawamura, Junichiro; Sugiura, Fumiaki; Sukegawa, Yasushi; Yoshioka, Yasumasa; Hida, Jin-Ichi; Hazama, Shoichi; Okuno, Kiyotaka.

Afiliación

Kawamura J; Department of Surgery, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Sugiura F; Department of Surgery, Seishukai Aiwa Hospital, Amagasaki, Hyougo 661-0953, Japan.
Sukegawa Y; Institute of Immunotherapy for Cancer, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Yoshioka Y; Department of Surgery, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Hida JI; Department of Surgery, Kindai University Faculty of Medicine, Osakasayama, Osaka 589-8511, Japan.
Hazama S; Department of Gastroenterological, Breast and Endocrine Surgery, Yamaguchi University Graduate School of Medicine, Ube, Yamaguchi 755-8505, Japan.
Okuno K; Department of Translational Research and Developmental Therapeutics against Cancer, Yamaguchi University School of Medicine, Ube, Yamaguchi 755-8505, Japan.

Oncol Lett ; 15(4): 4241-4247, 2018 Apr.

Article en En | MEDLINE | ID: mdl-29541190

Palabras clave

and adjuvant chemotherapy; clinical trial; colorectal cancer; oral chemotherapy; peptide vaccine therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Oncol Lett Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Grecia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google